跳至主要内容
临床试验/NCT02864355
NCT02864355终止不适用

Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients

Medical University of South Carolina2 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
53
试验地点
2
主要终点
Number of Participants With Cardiopulmonary Complications

研究概览

简要总结

The objective of this prospective, randomized controlled study is to ascertain whether the perioperative use of the FloTrac device to guide fluid and vasopressor management during esophagectomy improves patient outcomes. The primary outcome is cardiopulmonary complications; however, the secondary outcome of decreasing patient morbidity (acute renal injury, anastomotic leak, and overall length of both ICU (intensive care unit) and hospital stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years of age or older
  • Patients undergoing primary resection of esophageal cancer and resultant esophagectomy.

排除标准

  • Patients < 55kg or > 140 kg, based on literature regarding accuracy of FloTrac.
  • Patients with sustained preoperative dysrhythmias, based on literature regarding accuracy of FloTrac (atrial flutter and/or atrial fibrillation).
  • Patients with diagnosed NYHA class III-IV failure or documented EF < 30%
  • Patients who are unable/unwilling to consent for study procedures

结局指标

主要结局

Number of Participants With Cardiopulmonary Complications

时间窗: 7 days

Any documented cardiopulmonary complications present upon chart review.

次要结局

  • Hospital Length of Stay(30 days)
  • Anastomotic Leak Diagnosed Via Radiograph(7 days)
  • Number of Participants With Renal Injury(7 days)
  • Death(30 days)
  • Length of Intensive Care Unit Stay(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Does Perioperative Goal Directed Therapy Using... | 临床试验